By transfecting mouse fibroblast L-M cells with human genomic DNA, we have established and identified several clonal cell lines that stably express a high-affinity serotonin (5-HT)-uptake mechanism absent in untransfected host cells. One such cell line, L-S1, possesses features of 5-[3H]HT uptake similar to those previously characterized in the central nervous system and blood platelets: (i) specificity for 5-HT; (ii) antagonism by imipramine, a known inhibitor of high-affinity 5-HT uptake; (ii) both Nal and temperature dependences; (iv) kinetic saturability; and (v) high affinity for 5-HT (Km = 0.39 + 0. 10 jIM; V.. = 2.14 ± 0.55 pmol/min per mg of protein). This cell line can be used to compare the relative efficacies of known blockers of 5-HT uptake and thereby offers a rapid and reliable assay system for testing novel inhibitors of this system. Since L-S1 contains stably integrated human DNA in its genome, we postulate that the observed 5-HT-uptake system resulted from the expression of human gene(s) coding for the 5-HT transporter. Thus, cell lines such as L-S1 may represent novel means for screening and developing therapeutic agents specific for neurotransmitteruptake systems as well as substrates for the cloning and elucidation of the genes encoding the various neurotransmitter transporters.
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Inactivation of neurotransmitters, following their stimulated release into the synaptic cleft, is a key regulatory process in neurotransmission. For biogenic amine and amino acid neurotransmitters, the inactivation process is achieved mainly via transmitter-specific high-affinity transport systems present in the presynaptic neuron and/or surrounding glial cells (1) (2) (3) (4) (5) (6) . These transport mechanisms are also of significant clinical interest because some of their inhibitors are therapeutic agents for certain neurological disorders.
Although the physiology and pharmacology of a number of neurotransmitter transport systems including that for serotonin have been extensively studied (6) (7) (8) (9) (10) (11) (12) (13) , little is known about the biochemistry and molecular biology of any of these systems. With the hope of attaining such information, we report here the use of gene transfer (14) (15) (16) (17) in the establishment and identification of a clonal mouse fibroblast cell line, L-S1, that stably expresses a presumptively human highaffinity uptake system for serotonin (5-HT).
MATERIALS AND METHODS
Transfection of L-M Fibroblasts. Mouse L-M fibroblast cells (ATCC CCL 1.2) were plated in 100-mm culture dishes so that by the time of transfection the cell number would be about 106. Human genomic DNA and pSV2-neo, a plasmid bearing neomycin-resistance as a selectable marker (18) , were cotransfected essentially by the method of calcium phosphate precipitation (19) . After transfection, the cells were trypsinized and plated into 96-well plates. Selection of resistance to G418 (GIBCO; 400 tkg/ml) was maintained until transfectant colonies (typically three to five per well) were well established. Each well was then assayed for 5-[3H]HT uptake activities.
Identification of L-S1. During the initial screening, the entire bank of transfectants was assayed in parallel for 5- (20), labeled by the random priming method (21) , and used as the probe to hybridize the genomic blot. Both the hybridization and the posthybridization washings were done under stringent conditions. The blot was then exposed to XAR-5 film (Kodak) at -70°C in the presence of an intensifying screen (DuPont).
RESULTS
Identification of L-S1. More than 10,000 independent clones arising from transfection of human genomic DNA into mouse L-M fibroblasts were segregated in 96-well culture plates and assayed for their ability to accumulate extracellular 5-[3H]HT. During the uptake assay, intracellular alkaline phosphatase activities were also measured in parallel for each well and served as convenient normalizing values for 5-[3H]HT uptake. When the data for all of the assayed wells were plotted (Fig. 1) , the majority of the data points were distributed about a "main cluster" represented by a linear positive slope. In contrast, the rare high respondents in the assay were identified as points relatively high and above the cluster. The wells containing the high respondents were then expanded from stock plates and rescreened several times to ensure consistency of high responses. Further, the contents of these wells were also tested with imipramine ( . The data point representing the highresponding well that ultimately gave rise to L-S1 is encircled and labeled S1.
clonal cell lines with persistent uptake activities. One such cell line, L-S1, was chosen for further characterization.
Ligand Specificity. The expression ofa human 5-HT-uptake system in L-S1 cells was first shown by the significantly higher levels of5-[3H]HT uptake for L-S1 cells relative to that for L-M cells (Fig. 2) . Additionally, this enhanced uptake activity for L-S1 cells was inhibited by imipramine and unlabeled 5-HT (in both cases down to levels comparable with that of L-M cells) but not by any other neurotransmitter candidate tested (Fig. 2) . Thus, the uptake system manifested in L-S1 cells is quite specific for 5-HT. Inhibition by imipramine of 5-[3H]HT uptake by L-S1 cells is pharmacologically similar to its effect on high-affinity 5-HT uptake observed in other systems. This and the apparent ligand specificity suggest that L-S1 cells express a 5-HT-uptake system comparable to that of other systems. Ion and Temperature Dependences. Since neurotransmitter uptake is known to be both Na' and temperature dependent (1-6), these characteristics were also examined for the 5-HT-transport system in L-S1 cells. The concentration of Na'
(128 mM) in normal Ringer's solution was isoosmotically replaced by sucrose (256 mM), and the resulting solution was used to assay for 5-[3H]HT uptake by L-S1 cells. Table 1 shows that the presence of extracellular Na' was clearly essential for 5-HT uptake by L-S1. Replacement of Na' by sucrose abolished close to 90% of 5-[3H]HT uptake by L-S1 cells. Accumulation of5-[3H]HT by L-M cells in the presence or absence of Na' was comparable to that of L-S1 cells in the absence of Na'. Additionally, serotonin uptake by L-S1 cells was Ca2+ independent. 5-HT uptake by L-S1 was also temperature dependent ( Table 1) . Compared with the response at 37TC, the response of L-S1 cells at 0C was greatly diminished. In contrast, 5-[3H]HT uptake by L-M cells was temperature independent and comparable to that of L-S1 cells at 0C. These findings suggest that L-S1 cells accumulate 5-[3H]HT via an active transport process that is absent in L-M cells.
Autoradiographic Studies. In data not presented here, we also observed that the radioactivity measured in L-S1 truly represented transport of 5-[3H]HT into these cells: (i) autoradiography of these cells following incubation with 5-[3H]HT showed that most of the radioactivity was inside the cells rather than binding onto the cell surface; and (ii) when analyzed by reverse-phase HPLC, >90% of the radioactivity inside these cells comigrated with 5-[3H]HT.
Kinetic Analyses. Kinetic analyses, as shown by a Michaelis-Menten plot in Fig. 3 Upper, revealed that 5-[3H]HT uptake by L-S1 cells is a saturable process, one which is not present in L-M cells. Likewise, a Lineweaver-Burk plot (Fig.  3 Lower) of L-S1 cell uptake yielded a straight line with a discernable negative abscissa intercept, whereas the L-M cell plot did not. The abscissa and ordinate intercepts of the L-S1 cell plot were each extrapolated and inverted to yield an apparent Km of 0.39 ± 0.10 ,uM and an apparent Vmax of 2.14 + 0.55 pmol/min per mg of protein for its 5-HT uptake system. These values are comparable with those of highaffinity neuronal 5-HT-uptake systems previously reported (6-13) and indicate strongly that L-S1 cells accumulate 5-[3H]HT via a high-affinity mechanism. This indication is further strengthened by our observation that, when kinetic assays of L-S1 cells were performed in the presence of excess unlabeled 5-HT, the double-reciprocal plot of the L-S1 re- sponse ("L-S1 + 5-HT" line in Fig. 3 Lower) shifted to resemble that of L-M cells.
Drug-Inhibition Studies. The pharmacological fidelity of the 5-HT-uptake system expressed in L-S1 cells was assessed by using three known inhibitors of high-affinity 5-HT uptake: imipramine, nortriptyline, and desipramine. As the concentration of each drug increased, L-S1 cells exhibited decreasing levels of 5-[3H]HT-uptake activity (Fig. 4 Upper) . Within the given range of drug concentrations, all three drugs were able to saturably inhibit 5-[3H]HT uptake by L-S1 cells. From the uptake profiles, imipramine seemed the most potent inhibitor of all three, followed by nortriptyline and then desipramine (Fig. 4 Upper Inset) . When the logarithm of percent inhibition (derived by subtracting the percent-uptake values shown in Fig. 4 Upper Inset from 100) was plotted versus drug concentration, the resulting linear functions were used to estimate the IC50 values of the tested drugs (Fig. 4 Lower). For L-S1 cells, these values are as follows: imipramine, <0. these drugs in inhibiting 5-HT uptake (22) (23) (24) (25) . Thus, the known pharmacological characteristics of high-affinity 5-HT uptake seem to be expressed intact in L-S1 cells. Genomic Detection of Human DNA. We have also assessed the likelihood that the 5-HT-uptake system observed in L-S1 cells results from the integration and subsequent expression of human DNA transferred into L-M cells. Southern blots (26) ofEcoRI-digested genomic DNAs for both L-M and L-S1 cells were hybridized with a probe specific for human Alu sequences. A representative autoradiogram (Fig. 5) indicated that L-S1 indeed integrated human DNA, as shown by discrete hybridizing DNA fragments within an extensive smear pattern. In contrast, no discernable hybridizing signal was observed with L-M cells. By comparison of the overall hybridizing strength observed for L-S1 DNA with that of known quantities of human genomic DNA, we conservatively estimate that L-S1 contains about 5 x 106 bp of stably integrated human DNA. 
DISCUSSION
Two of the essential regulatory processes of synaptic transmission are (i) the activation of a neurotransmitter receptor by the release of the appropriate transmitter and (ii) the inactivation of this transmitter, mainly by an uptake (transport) mechanism into the presynaptic neuron and/or surrounding glial cells. In recent years, there have been major advances in our understanding of the molecular basis of the activation process due in large part to the cloning of the genes for a number of these receptors (27) (28) (29) (30) and the subsequent elucidation of their structure-function relationships (31) (32) (33) . In contrast, even though the physiology and pharmacology of many uptake-mediated inactivation processes are fairly well understood, very little information exists regarding the biochemistry and molecular biology of the transport proteins (transporters) responsible for the inactivation mechanisms.
We have attempted to identify and characterize the molecular components of these transport systems by transfecting human genomic DNA into mouse fibroblast L-M cells and isolating clones capable of high-affinity neurotransmitter uptake. Mouse L fibroblasts are suitable hosts for the expression ofexogenously introduced DNA (14) and have been used successfully in gene transfer schemes to identify previously unknown genes (15) (16) (17) . To date, we have used this approach to identify clones that possess human high-affinity transport mechanisms for 5-HT, glycine, and glutamate, respectively (unpublished data).
We report here the isolation and characterization of one such clonal cell line, L-S1, which possesses a high-affinity uptake system for 5-HT. This system is characterized by ligand specificity, Na+ and temperature dependence, antagonizability by known blockers (nortriptyline, imipramine, and desipramine), and saturable and high-affinity uptake kinetics. In particular, the Km and Vma values are well within the range of such parameters measured for 5-HT-uptake systems in the central nervous system and blood platelets (6) (7) (8) (9) (10) (11) (12) (13) .
The presence of human DNA in L-S1 cells correlates with the expression of a 5-HT-uptake system. The possibility exists that the process of integrating human DNA actually activated expression of an endogenous mouse gene coding for a 5-HT-uptake system. Previous studies using transfection schemes analogous to that described in this report to clone integrated human genes (15) (16) (17) seem to collectively favor the former explanation. Therefore, we tentatively postulate that L-S1 cells integrated and subsequently expressed genes encoding human 5-HT transporters.
The availability of a model system such as L-S1 should facilitate several experimental approaches, as outlined below, whereby the molecular, functional, and pharmacological characteristics of 5-HT uptake can be better understood in Finally, many pharmaceuticals currently used for the treatment of such disorders as depression, obesity, and alcoholism, postanoxic intention myoclonus, acute and chronic pain, and sleep disorders are known to be inhibitors of5-HT uptake (6) . Consequently, even before molecular insights on the 5-HT transporter can be attained, the existence of the L-S1 cell line makes it immediately feasible to use it for a rapid and reliable assay to test the efficacy of potential 5-HT uptake blockers as novel therapeutic agents. In this regard, we examined the relative potencies of three antidepressants in terms of inhibiting 5-[3H]HT uptake by L-S1 cells. The derived rank order of potencies, as well as the calculated IC50 values, were in excellent agreement with known characteristics of these drugs in inhibiting 5-HT uptake, as elucidated in other models of 5-HT uptake. This result suggests that the 5-HT-uptake system observed in L-S1 cells is pharmacologically qualified for studies of drug interactions with 5-HT uptake. Although other models of 5-HT uptake, such as in vitro derivations (e.g., synaptosomes), blood platelets, or cultured cell lines are available for drug-testing purposes, L-S1 is potentially superior in the following respects: (i) levels of 5-HT uptake in other models may not be consistent between different preparations; (ii) the presence of other neurotransmitter and neuroregulatory mechanisms (e.g., transmitter receptors, other transmitter-uptake systems, etc.) may impede quantitative analyses of the 5-HT transporter; and (iii) other models may not be as amenable to quantitative preparation and accommodate simultaneous evaluation of multiple drugs. These considerations suggest the utilities of the L-S1 cell line in developing and evaluating novel therapeutic agents interacting with 5-HT-uptake mechanisms.
In view of the apparent fidelity with which known physiological, biochemical, and pharmacological characteristics of the 5-HT-uptake system are manifested in L-S1, the results reported here demonstrate the feasibility of using the genetransfer approach to genetically reconstitute transport systems of other neurotransmitters. Transfected cell lines such as L-Sl may prove to be valuable experimental substrates with which to further unravel the molecular, biochemical, and pharmacological mechanisms ofhigh-affinity neurotransmitter transport.
